By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Molecular Templates Inc. 

610 University Avenue, Room 7-117

Toronto  Ontario  M5G 2M9  Canada
Phone: 416-946-2875 Fax: 416-946-6529



Company News
Molecular Templates Inc. Announces Start Of Phase 1 Clinical Trial Of MT-3724 In Refractory Non-Hodgkin’s Lymphoma 3/5/2015 10:06:12 AM
Veristat, Inc. And Molecular Templates Inc. Enter Into Preferred Provider Agreement For Refractory Non-Hodgkin’s B-Cell Lymphoma trial 10/13/2014 9:27:46 AM
Molecular Templates Inc. Presents Preclinical Data On CD38-Targeted Engineered Toxin Body (ETB) At The American Association For Cancer Research Special Conference, Hematologic Malignancies: Translating Discoveries To Novel Therapies 9/25/2014 2:09:42 PM
Molecular Templates Inc. Announces Completion Of $12 Million Series C Financing 9/15/2014 11:07:20 AM
Molecular Templates Inc. Templates Announces FDA Approval Of Investigational New Drug Application For CD20 Internalizing Immunotoxin MT-3724 9/8/2014 10:49:56 AM
Molecular Templates Inc. Presents Preclinical Data On Engineered Toxin Bodies (ETBs) At The American Association for Cancer Research Annual Meeting 4/18/2014 6:37:24 AM
Molecular Templates Inc. Announces $8.5 Million Series C Financing and $10.6 Million Grant Funding 10/8/2013 6:33:18 AM
Molecular Templates Inc. to Present at 2013 Biotechnology Industry Organization (BIO) International Convention 4/22/2013 6:35:05 AM
Molecular Templates Inc. Announces RNAi Drug-Delivery Research Collaboration with Alnylam Pharmaceuticals (ALNY) 5/4/2011 7:55:25 AM
Molecular Templates Inc. Announces Research Collaboration with Memorial Sloan-Kettering Cancer Center 4/15/2011 8:27:22 AM